For example, methotrexate, a dihydrofolate reductase (DHFR) inhibitor, is widely used in tumor chemotherapy; and pemetrexed is used for the treatment of non-small cell lung cancer targeting TS and AICAR convertase. This evidence concerns the gene DHFR and non-small cell lung carcinoma.